SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Microcap & Penny Stocks | The Microcap Kitchen: Stocks 5¢ to $5

Previous 10 | Next 10 
To: ACAN who wrote (107598)4/18/2012 9:59:31 AM
From: Findit   of 111076
 
ACAN - NEIK looks good here. Did sell 1/3 but looking for more the next few weeks. May add some on dips. Hope you got some. Jim

Share Recommend | Keep | Reply | Mark as Last Read

To: Catfish who wrote (107550)4/18/2012 10:00:35 AM
From: Brasco One1 Recommendation   of 111076
 

NeuroMetrix Files 510(k) for SENSUS™ Pain Therapy Device



WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO - News), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it has filed a premarket notification, or 510(k), with the Food and Drug Administration (FDA) for its SENSUS Pain Therapy device.

SENSUS is a non-invasive transcutaneous electrical nerve stimulator intended to be used in the symptomatic relief and management of chronic intractable pain, such as painful diabetic neuropathy. SENSUS employs the same sophisticated nerve stimulation technology as the Company’s NC-stat® DPNCheck™ device, and includes advanced features that the Company believes may address the technical and clinical limitations of existing nerve stimulators. The device also includes technology to maximize patient compliance, which is one of the fundamental challenges with pain therapy.

Painful diabetic neuropathy affects as many as 10-20% of people with diabetes, and is a serious and disabling complication of diabetic peripheral neuropathy (DPN). The pain is typically managed pharmacologically; however, many patients remain undertreated. Recent evidence based reviews have suggested that transcutaneous electrical nerve stimulators may be useful in managing painful diabetic neuropathy.

“The filing of a 510(k) for SENSUS represents a key milestone in this product development program,” said Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer, NeuroMetrix. “We look forward to feedback from the FDA and working towards a timely clearance. Once commercialized, we believe that SENSUS will complement NC-stat DPNCheck, our sural nerve conduction test for DPN, and move us towards our goal of creating a unique and valuable diabetic neuropathy product portfolio and franchise.”

About NeuroMetrix

NeuroMetrix is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company currently markets products for the detection, diagnosis, and monitoring of diabetic neuropathies such as diabetic peripheral neuropathy and median neuropathy (carpal tunnel syndrome). For more information, please visit http://www.neurometrix.com.





Contact:
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
Chief Financial Officer

Share Recommend | Keep | Reply | Mark as Last Read

From: Catfish4/18/2012 10:13:18 AM
1 Recommendation   of 111076
 
LQMT - .181 This is getting some attention this AM:

Liquidmetal Technologies (LQMT) Jumps on iPhone 5 Rumors

FREE Breaking News Alerts from StreetInsider.com!

April 18, 2012 9:44 AM EDT
Traders are eying Liquidmetal Technologies Inc. (OTCBB: LQMT) following reports from patentlyapple.com that Apple's (Nasdaq: AAPL) iPhone 5 is rumored to be shifting from glass to liquidmetal.

Patentlyapple.com citing Korea's Electric Times Internet reported, "the next flagship phones of the companies are expected to adopt unprecedented materials for their main bodies, that is, ceramic for the Galaxy S3 and liquidmetal for the iPhone5, both being thin, light and highly resistant to external impacts."

Shares of LQMT are popping up 33% in early going Wednesday.

Share Recommend | Keep | Reply | Mark as Last Read

To: Catfish who wrote (107594)4/18/2012 10:28:04 AM
From: catchmeifyoucan1 Recommendation   of 111076
 
MKRS - Keep them coming... ! today's release means that this is an ongoing concern. More to come and perhaps even bigger... IMO.

Share Recommend | Keep | Reply | Mark as Last Read

To: Findit who wrote (107588)4/18/2012 10:51:11 AM
From: rrufff1 Recommendation   of 111076
 
NEIK .053 - got out. Have to admit I never thought it would run after the history of inaction, lack of follow through.

That being said, I think it's gotten ahead of the details of the sale of past business, proposed new business.
After deals close, should be about 65 million shares and about $5 million debt. Tough to argue more than about .05 until they show revenues. I suspect that a lot of the current action is typical IHub promotional and, yes, it can continue to run.

I think it retraces for another opportunity. Last few months "excitement" have sort of made up for years of zzzzzz.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: rrufff who wrote (107603)4/19/2012 1:27:59 AM
From: Findit1 Recommendation   of 111076
 
NEIK I sold some today at .05. Nice gain. Will buy that back on a dip. The promoters over at IHUB appear to be working well together. Plus I don't see the basher pros showing up yet. So I think it will continue to be a good swing trade for a while. Jim

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

From: Catfish4/19/2012 9:09:51 AM
   of 111076
 
ROSG - .16 This is a stock to watch closely in the AM. They just did an offering for $1.38M....but, stock is getting some pre-market activity with the following PRs just out:



http://custom.fmg.dowjones.com/custom/tdameritrade-com/html-story.asp?guid={4915f947-70f8-4b90-8f1b-8679de11fad8}

Rosetta Genomics: Mir-34a Aims To Contribute To Tumor-Suppressive Effects Of Activated p53 Protein

http://www.marketwatch.com/story/rosetta-genomics-receives-key-european-patent-in-oncology-2012-04-19

Rosetta Genomics Receives Key European Patent in Oncology
Patent Awarded for the Use of miR-34a for the Preparation of Pharmaceuticals for Treating p53-Negative Cancers

Share Recommend | Keep | Reply | Mark as Last Read

From: Catfish4/19/2012 9:14:29 AM
   of 111076
 
WEBM - .97 This may gap up....now at $1.20 in pre-market.

WebMediaBrands Introduces New Social Media Services and Relaunches AllFacebook.com

NEW YORK, Apr 19, 2012 (BUSINESS WIRE) -- WebMediaBrands Inc. /quotes/zigman/111303/quotes/nls/webm WEBM -4.08% today has announced the launch of Morning Social Media Newsfeed, a daily email compiling the most up-to-date social media news from around the world and AppNewser.com, covering the world of smartphone and tablet apps; from spotting the latest trends, researching apps that flourish in social networks like Facebook, Twitter and Spotify, to highlighting the most popular developers and exploring the boom of social gaming apps.

Additionally, AllFacebook.com, the number one resource about the social network, has undergone a redesign to better present and share breaking news, analysis and features all about Facebook. AllFacebook has more than 1 million unique monthly visitors and approximately 450,000 likes on its Facebook page.

"WebMediaBrands has long been the leader in providing daily news, analysis, research, job boards and trade shows for the rapidly growing social media field," stated Alan M. Meckler, Chairman and CEO of WebMediaBrands. "We expect to shortly announce the launch of several new research products under the umbrella of Appdata.com," added Meckler.

About WebMediaBrands Inc.

WebMediaBrands Inc. /quotes/zigman/111303/quotes/nls/webm WEBM -4.08% ( http://www.webmediabrands.com ), headquartered in New York, NY, is a leading Internet media company that provides content, education, and career services to media and creative professionals through a portfolio of vertical online properties, communities, and trade shows. The Company's online business includes: (i) mediabistro.com, a leading blog network providing content, education, community, and career resources (including the industry's leading online job board) about major media industry verticals including new media, social media, Facebook, TV news, sports media news, advertising, public relations, publishing, design, mobile; (ii) InsideNetwork.com, a leading network of online properties providing original market research, data services, news, and job listings on the Facebook platform, on social gaming, and on mobile applications ecosystems; and (iii) SemanticWeb.com, a leading blog providing content, education, community resources and career resources on the commercialization and application of Semantic Technologies, Linked Data and Big Data. The Company's online business also includes community, membership and e-commerce offerings including a freelance listing service, a marketplace for designing and purchasing logos (stocklogos.com) and premium membership services. The Company's trade show and educational offerings include conferences, online and in-person courses, and video subscription libraries on topics covered by the Company's online business.

View all WebMediaBrands press releases: www.webmediabrands.com/corporate/press.html

SOURCE: WebMediaBrands Inc.




WebMediaBrands Inc.
Ismaela Best, 212-547-7887
Director of Marketing
press@webmediabrands.com

Share Recommend | Keep | Reply | Mark as Last Read

From: Catfish4/19/2012 9:21:06 AM
   of 111076
 
LQMT - Bid/Ask moving up in pre-market...this may gap up again. Lot of speculation on LQMT I-Hub board.

Share Recommend | Keep | Reply | Mark as Last Read

From: weff4/19/2012 10:50:05 AM
   of 111076
 
RVUE volume showing up

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.